@Article{ecn.2016.0386,
AUTHOR = {Shi-Min Yuan},
TITLE = {Pulmonary artery hypertension: pertinent vasomotorial cytokines},
JOURNAL = {European Cytokine Network},
VOLUME = {28},
YEAR = {2017},
NUMBER = {1},
PAGES = {1--7},
URL = {http://www.techscience.com/ECN/v28n1/65523},
ISSN = {1952-4005},
ABSTRACT = {Pulmonary artery hypertension is a syndrome that shows similar clinical and pathophysiological features
characterized by elevated pulmonary arterial pressure and resistance. There have been a series of hypotheses
trying to describe the development of pulmonary artery hypertension; however, none of them perfectly explains
its pathogenesis. To highlight the pathogenesis, novel vasomotorial cytokines including hypoxia-inducible factor-1α
endothelin-1, urotensin II, Krüppel-like factor 4, calcitonin gene-related peptide, angiopoietins and serotonin
closely related to pulmonary artery hypertension are discussed. The development of the new agents relating to these
cytokines may improve the relevant treatment strategies.},
DOI = {10.1684/ecn.2016.0386}
}